Chicago researchers warn against using smart pills

Researchers at the University of Illinois at Chicago (UIC) are warning patients and physicians against using smart pills until research can prove their successfulness.

UIC professors Eric Swirsky and Andrew Boyd recently published a paper in the American Journal of Bioethics cautioning healthcare providers and policymakers about using smart pills to track patient care.

Smart pills are described as prescription medications with edible electronic sensors that send wireless messages to devices outside the body after they’re ingested. People who support the technology hope they can help patients and doctors track drug regimen compliance, increase patient adherence and save money, while opponents of the pills have concerns about patient privacy and data sharing.

However, the authors questioned the benefits of the pills, saying there’s no evidence to suggerst smart pills can improve a patient’s life. They also said using using the technology challenges current research that shows patients benefit from working directly with their physicians.

“It is naive to think that this type of surveilled compliance with provider-recommended drug treatments will function like a magic pill. More likely, it will just challenge the ingenuity of patients,” Swirsky said in a statement.

The authors said smart pills should be evaluated on their clinical efficacy against the “standard of care drugs, like any other intervention, not based only on compliance or cost savings.”

“Smart pills are a dangerous reduction of the provider-patient relationship and there is no shortcut to improving patient adherence, which happens in a larger framework of home, work and clinical environments, not to mention perceptions and emotions,” Swirsky said. “This technology dumbs down an issue that is often very complex in the hopes of quickly solving an expensive medical challenge.”

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”